Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2007 1
2008 1
2011 1
2012 1
2013 1
2014 1
2020 3
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study.
Ruiz-Medina S, Gil S, Jimenez B, Rodriguez-Brazzarola P, Diaz-Redondo T, Cazorla M, Muñoz-Ayllon M, Ramos I, Reyna C, Bermejo MJ, Godoy A, Torres E, Cobo M, Galvez L, Rueda A, Alba E, Ribelles N. Ruiz-Medina S, et al. Among authors: bermejo mj. Cancers (Basel). 2021 Jun 28;13(13):3215. doi: 10.3390/cancers13133215. Cancers (Basel). 2021. PMID: 34203185 Free PMC article.
Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients.
Ribelles N, Jerez JM, Rodriguez-Brazzarola P, Jimenez B, Diaz-Redondo T, Mesa H, Marquez A, Sanchez-Muñoz A, Pajares B, Carabantes F, Bermejo MJ, Villar E, Dominguez-Recio ME, Saez E, Galvez L, Godoy A, Franco L, Ruiz-Medina S, Lopez I, Alba E. Ribelles N, et al. Among authors: bermejo mj. Eur J Cancer. 2021 Feb;144:224-231. doi: 10.1016/j.ejca.2020.11.030. Epub 2020 Dec 26. Eur J Cancer. 2021. PMID: 33373867
Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilator.
Jimenez E, Astbury C, Albayaty M, Wählby-Hamrén U, Seoane B, Villarroel C, Pujol H, Bermejo MJ, Aggarwal A, Psallidas I. Jimenez E, et al. Among authors: bermejo mj. Respir Res. 2020 Sep 9;21(Suppl 1):211. doi: 10.1186/s12931-020-01470-5. Respir Res. 2020. PMID: 32907576 Free PMC article. Clinical Trial.
16 results